AbCellera Biologics Inc. (ABCL)
NASDAQ · Healthcare
AbCellera Biologics Inc. Net Income 2019–2025
AbCellera Biologics Inc. annual/quarterly net income history and growth rate from 2019 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- AbCellera Biologics Inc. net income for the quarter ending March 31, 2026 was -43.2 M, a 5.38% decrease year-over-year.
- AbCellera Biologics Inc. net income for the twelve months ending March 31, 2026 was -180.6 M, a 14.86% increase year-over-year.
- AbCellera Biologics Inc. annual net income for 2025 was -146.4 M, a 10.10% decrease from 2024.
- AbCellera Biologics Inc. annual net income for 2024 was -162.9 M, a 11.24% increase from 2023.
- AbCellera Biologics Inc. annual net income for 2023 was -146.4 M, a 192.35% decrease from 2022.
- AbCellera Biologics Inc. annual net income for 2022 was 158.5 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
AbCellera Biologics Inc. Net Income — FAQ
AbCellera Biologics Inc. (ABCL) net income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is AbCellera Biologics Inc.'s net income?
AbCellera Biologics Inc. (ABCL) reported net income of -$146M for fiscal 2025.
Where can I see ABCL's net income history?
The chart and table above show AbCellera Biologics Inc.'s net income by year and by quarter, including the growth rate.